Ohio State’s Department of Family Medicine is currently enrolling for a research study for Type 2 diabetics who are inadequately controlled when not taking any medication for their diabetes. This study compares the effectiveness of treatment with sitagliptin (Januvia) and pioglitazone (Actos) taken together compared to taking sitagliptin (Januvia) and pioglitazone (Actos) separately. Participants will receive study related care, study medication, lab tests, glucose monitoring supplies, and diet and exercise counseling at no charge. Participation will last up to 65 weeks and there will be 11 visits to our clinic.
If you are interested in learning more about this study, contact Paula Smailes at (614) 293-3644.